Anti‐CD19 CAR T‐cell therapy for patients with Richter transformation: A LYSA study from the DESCAR‐T registry
Click on the article title to read more.
Related Articles
A strategy for multimodal integration of transcriptomics, proteomics, and radiomics data for the prediction of recurrence in patients with IDH‐mutant gliomas
What’s new? Isocitrate dehydrogenase (IDH)-mutant gliomas typically affect young adults and invariably progress toward increasingly malignant phenotypes, despite treatment. Recurrence often is unpred…
Parental education in pediatric dysphagia: A comparative analysis of three large language models
Objectives This study evaluates the effectiveness of three widely used large language models (LLMs)—ChatGPT-4, Copilot, and Gemini—in providing accurate, reliable, and understandable answers to freq…
Outcomes of Allogeneic HCT in Hodgkin Lymphoma in the Era of Checkpoint Inhibitors: A Joint CIBMTR and EBMT Analysis.
Key Points. Prior exposure to CPI is associated with increased PFS due to decreased incidence of relapse after HCT, suggesting an increased GVL.PTCy based
Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study
Key PointsOur results indicate that ASCT is a curative option for patients with chemosensitive disease especially in CR after salvage.ASCT could still be c
Bridging radiotherapy before chimeric antigen receptor T cells for B-cell lymphomas: an ILROG multicenter study
Key PointsBr-RT before CAR-T was well tolerated with minimal toxicity in this large multicenter study.Comprehensive Br-RT and LDH normalization after RT bu
Immunological consequences of CAR T-cell therapy: an analysis of infectious complications and immune reconstitution
Key PointsCAR T cells induce a cellular and humoral immunodeficiency resulting in an initial susceptibility for bacterial and later viral infections.Severe
SGLT2 inhibition promotes glomerular repopulation by cells of renin lineage in experimental kidney disease
Aim Sodium glucose co-transporter-2 (SGLT2) inhibitors stimulate renal excretion of sodium and glucose and exert renal protective effects in patients with (non-)diabetic chronic kidney disease…
The transcription factor RIP140 regulates interferon γ signaling in breast cancer
What’s new? Interferon γ (IFNγ) is a key player in breast cancer, with the potential to induce apoptosis and to shift tumors into a dormant…
We are on the right track for mantle cell lymphoma
Commentary on: Alzahrani et al. Therapeutic advances and gradual improvement in overall survival in mantle cell lymphoma over 4 decades. Br J Haematol 2025 (Online ahead…
